Glenmark Pharmaceuticals Inc., USA, has announced the commercial availability of Vancomycin Hydrochloride for Injection USP in three single-dose vial strengths: 750 mg/vial, 1.25 g/vial, and 1.5...
The government of India is being urged by its pharmaceutical industry to negotiate with Washington from a position of power on tariffs set to take effect next week, rather than yield to the pressure...
In an interaction with India Pharma Outlook, Sudheendra Kulkarni, MD & CEO of Ferring Pharmaceuticals India shares insights about India's evolution from volume-based to value-based healthcare. He emphasizes the necessity of...
Digital Personal Data Protection Act received the assent of the President on 11th August 2023. This Act provides for the processing of digital personal data in a manner that recognizes both the right of individuals
Indian companies can export pharmaceutical products to Penza region of Russia as many European pharma suppliers have exited the market.
Marksans Pharma has stated that its pharmaceutical manufacturing unit situated at Plot A-1, Phase 1-A, Verna Industrial Estate, Goa, India, has been granted the approval from the...
By the end of this year, India will commence domestic manufacture of Rifampicin, a first-line anti-tubercular medicine. According to official sources, “Rifampicin is at an advanced stage of execution and is expected to get commissioned later this yea
The US FDA said that Sun and Zydus Pharmaceuticals are recalling products from the American market due to manufacturing errors. Sun Pharma Industries, Inc. based in New Jersey is recalling 9,840 bottles of Morphine Sulfate extended-release tablets fo
Poly Medicure is one of the world’s largest manufacturers of medical devices and has recently received Medical Device Regulation (MDR) validation for 54 of its products across diverse specialties such as infusion therapy, surgery & wound care....
On Thursday, Sun Pharmaceutical Industries announced that it has requested shareholders' consent for related-party transactions (RPTs) totaling about $1 billion for FY26...